Clinical Pharmacology and Drug Toxicity Practice Questions

Q: Therapeutic Drug Monitoring (TDM) is indicated for which of the following drugs, EXCEPT?

Metformin. **Explanation:** Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring drug concentrations in the blood to maintain a therapeutic range. It is indicated for drugs with a **narrow therapeutic index**, where the difference between the effective dose and the toxic dose is minimal, or when there is a poor correlation between dose and clinical effect. **Why Metformin is the correct answer:** Metformin is a Biguanide used for Type 2 Diabetes. Its clinical efficacy is easily monitored by measuring **surrogate markers** (Blood Glucose levels and HbA1c) rather than plasma drug levels. Furthermore, Metformin has a wide therapeutic window, and its most serious side effect, lactic acidosis, does not correlate linearly with plasma concentrations, making TDM unnecessary. **Why the other options are incorrect:** * **Theophylline:** Has a narrow therapeutic index (10–20 µg/mL). Toxicity can lead to fatal arrhythmias and seizures; thus, TDM is mandatory. * **Lithium:** Used in Bipolar Disorder, it has an extremely narrow window (0.6–1.2 mEq/L). Levels >1.5 mEq/L are toxic, necessitating frequent monitoring. * **Phenytoin:** Exhibits **zero-order (saturation) kinetics** at therapeutic doses. Small dose increments can lead to disproportionately large increases in plasma levels and toxicity (nystagmus, ataxia). **High-Yield Clinical Pearls for NEET-PG:** * **Indications for TDM:** Narrow therapeutic index, non-compliance suspected, drugs with high inter-individual pharmacokinetic variation, and drugs whose toxicity is difficult to distinguish from the disease (e.g., Digoxin). * **TDM is NOT needed for:** Drugs with easily measurable physiological effects (e.g., Antihypertensives, Oral Hypoglycemics, Anticoagulants like Warfarin where PT/INR is used). * **Common TDM Drugs:** Digoxin, Cyclosporine, Aminoglycosides (Gentamicin), Vancomycin, and Antiepileptics (Valproate, Carbamazepine).

Q: Which of the following statements about cetirizine is false?

It has good central nervous system penetration.. **Explanation:** **1. Why Option C is the correct (False) statement:** Cetirizine is a **second-generation H1-antihistamine**. Unlike first-generation agents (e.g., diphenhydramine), second-generation drugs are characterized by their **high polar nature** and low lipid solubility. This prevents them from crossing the blood-brain barrier (BBB) effectively. Therefore, cetirizine has **poor central nervous system (CNS) penetration**, resulting in minimal sedation compared to older antihistamines [1, 2]. **2. Analysis of Incorrect Options:** * **Option A:** This is true. Cetirizine belongs to the second generation of H1 blockers, which are preferred for allergic rhinitis and urticaria due to their longer duration of action and lack of anticholinergic side effects. * **Option B:** This is true. Cetirizine is the active acid metabolite of **hydroxyzine** (a first-generation antihistamine) [1]. * **Option D:** This is true. Beyond blocking H1 receptors, cetirizine possesses additional anti-inflammatory properties, including the inhibition of mast cell degranulation and the release of histamine and other inflammatory mediators. **Clinical Pearls for NEET-PG:** * **Levocetirizine** is the R-enantiomer of cetirizine, offering higher potency and potentially fewer side effects. * While classified as "non-sedating," cetirizine is the **most sedative** among the second-generation agents (more so than fexofenadine or loratadine). * It is primarily excreted unchanged in the urine; hence, dose adjustment is required in **renal impairment**. * Unlike terfenadine or astemizole, cetirizine does **not** cause QTc prolongation or Torsades de Pointes.

Q: Which of the following statements regarding carbon monoxide toxicity is FALSE?

Cytochrome toxicity is lethal. **Explanation:** Carbon monoxide (CO) toxicity is a high-yield topic in NEET-PG, focusing on its unique pathophysiology and management. **1. Why Option A is the Correct (False) Statement:** While CO does bind to **Cytochrome a3 (Cytochrome oxidase)** in the electron transport chain, this is **not** the primary cause of lethality. The lethal effect of CO is primarily due to its massive affinity for Hemoglobin (200–250 times greater than Oxygen), leading to severe tissue hypoxia. Cytochrome toxicity occurs only at extremely high concentrations that are usually secondary to the respiratory failure caused by carboxyhemoglobinemia. **2. Analysis of Other Options:** * **Option B (Treated by 5% CO2):** This is a **true** statement regarding management. Carbogen (95% O2 + 5% CO2) is used because CO2 acts as a potent respiratory stimulant, increasing minute ventilation and accelerating the clearance of CO from the blood. * **Option C (PO2 is decreased):** This is a **true** statement. While the *dissolved* oxygen (PaO2) might initially remain normal, the total oxygen content of the blood is severely decreased because CO occupies the binding sites on hemoglobin, preventing oxygen transport. * **Option D (Shift HbO2 curve to left):** This is a **true** and classic finding. CO binding to one heme site increases the affinity of the remaining three sites for oxygen. This prevents the release of oxygen to the tissues (increased "stickiness"), shifting the curve to the **left**. **Clinical Pearls for NEET-PG:** * **Cherry-red discoloration** of skin/mucosa is a classic (though often post-mortem) sign. * **Pulse Oximetry (SpO2)** is unreliable because it cannot distinguish between HbO2 and Carboxy-Hb. * **Treatment of choice:** 100% High-flow Oxygen (reduces half-life of CO from 320 to 80 mins). **Hyperbaric Oxygen** is indicated in severe cases (pregnancy, coma, or CO-Hb >25%).

Q: Which of the following drugs are used in the treatment of obesity?

All of the above. **Explanation:** The treatment of obesity involves pharmacological agents that target different physiological pathways: fat absorption, appetite suppression, and the endocannabinoid system. * **Orlistat:** This is a **gastric and pancreatic lipase inhibitor**. It works locally in the GI tract to prevent the breakdown of dietary fats (triglycerides) into absorbable free fatty acids. Approximately 30% of dietary fat is excreted in the feces. * **Sibutramine:** This is a **combined norepinephrine and serotonin reuptake inhibitor (SNRI)**. It acts centrally to promote satiety and increase metabolic rate. However, it is important to note that it has been withdrawn in many countries due to increased cardiovascular risks (MI and stroke). * **Rimonabant:** This is a **selective Cannabinoid-1 (CB1) receptor antagonist**. By blocking these receptors in the hypothalamus and adipose tissue, it reduces appetite and improves lipid metabolism. Like Sibutramine, it was withdrawn from the market due to serious psychiatric side effects, including depression and suicidal ideation. Since all three drugs have been clinically used and approved (historically or currently) for weight management, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** 1. **Orlistat Side Effects:** Steatorrhea (oily spotting) and deficiency of fat-soluble vitamins (A, D, E, K). 2. **Newer FDA-approved drugs:** **Lorcaserin** (5-HT2C agonist), **Phentermine/Topiramate** combination, and **Liraglutide/Semaglutide** (GLP-1 analogues). 3. **Semaglutide** is currently considered the most effective pharmacological agent for weight loss. 4. **Bupropion + Naltrexone** is another combination used for obesity management.

Q: Which of the following drugs has a narrow therapeutic index?

All of the above. **Explanation:** The **Therapeutic Index (TI)** is the ratio of the dose that produces toxicity to the dose that produces the desired clinically effective response ($TI = TD_{50} / ED_{50}$) [1]. Drugs with a **narrow therapeutic index (NTI)** have a very small margin between their effective and toxic doses [1]. For these drugs, small fluctuations in plasma concentration can lead to serious therapeutic failure or severe adverse effects, often requiring **Therapeutic Drug Monitoring (TDM)** [1], [2]. * **Phenytoin (Option A):** An antiepileptic that exhibits zero-order kinetics at higher therapeutic levels [1]. Small dose increases can lead to disproportionate rises in plasma levels, causing ataxia and nystagmus [1], [2]. * **Lithium (Option B):** Used in bipolar disorder, it has a very narrow window (0.6–1.2 mEq/L) [3]. Levels above 1.5 mEq/L are toxic, leading to tremors, seizures, and renal impairment [3]. * **Digoxin (Option C):** A cardiac glycoside used in heart failure and AFib. Its therapeutic range is 0.5–2.0 ng/mL. Toxicity (nausea, yellow-green vision, arrhythmias) is common, especially in the presence of hypokalemia. Since all three drugs require precise dosing and monitoring to avoid toxicity, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for NTI Drugs:** "**W**ith **L**ots of **P**recision, **T**he **D**octor **C**an **S**ave **L**ives" (**W**arfarin, **L**ithium, **P**henytoin, **T**heophylline, **D**igoxin, **C**arbamazepine, **S**odium Valproate, **L**evothyroxine). * **TDM is NOT required for:** Drugs with a wide TI (e.g., Penicillin), drugs with easily measurable clinical effects (e.g., Antihypertensives via BP), or "hit-and-run" drugs (e.g., Omeprazole).

Q: All of the following drugs can cause hepatic granuloma, EXCEPT:

Carbon tetrachloride. **Explanation:** The correct answer is **Carbon tetrachloride (CCl₄)**. The underlying medical concept here is the distinction between **idiosyncratic drug reactions** and **direct hepatotoxicity**. 1. **Why Carbon tetrachloride is the correct answer:** Carbon tetrachloride is a potent, direct hepatotoxin. It does not cause granulomatous inflammation; instead, it causes **centrilobular (Zone 3) hepatic necrosis** and **steatosis** (fatty change). Its toxicity is mediated by the cytochrome P450 system, which converts CCl₄ into the highly reactive free radical **CCl₃·**, leading to lipid peroxidation and membrane damage. 2. **Why the other options are incorrect:** Hepatic granulomas are typically a manifestation of an **idiosyncratic hypersensitivity reaction** (Type IV delayed hypersensitivity). * **Quinidine:** A classic cause of drug-induced non-caseating granulomas in the liver. * **Sulfonamides:** Frequently associated with hypersensitivity reactions leading to granulomatous hepatitis. * **Carbamazepine:** An anticonvulsant known to cause idiosyncratic liver injury, often presenting with granulomas and occasionally vanishing bile duct syndrome. **NEET-PG High-Yield Pearls:** * **Common drugs causing Hepatic Granulomas:** Remember the mnemonic **"S-A-L-T-Q-C"** (Sulfonamides, Allopurinol, Lipid-lowering agents/Statins, Trazodone, Quinidine, Carbamazepine). Other causes include Hydralazine and Methyldopa. * **Carbon Tetrachloride** is the classic "textbook" example of a toxin causing **centrilobular necrosis**, similar to Acetaminophen (Paracetamol) overdose. * **Systemic causes of hepatic granulomas:** Sarcoidosis (most common), Tuberculosis, Histoplasmosis, and Schistosomiasis.

Q: Which of the following is NOT a side effect of cyclosporine?

Bone marrow suppression. **Explanation:** Cyclosporine is a calcineurin inhibitor used primarily as an immunosuppressant to prevent organ transplant rejection and treat autoimmune conditions. **Why Bone Marrow Suppression is the correct answer:** Unlike most immunosuppressive agents (such as Azathioprine or Mycophenolate Mofetil), **Cyclosporine is notably non-myelosuppressive.** It acts specifically by inhibiting the transcription of Interleukin-2 (IL-2) in T-cells. Because it does not affect rapidly dividing progenitor cells in the bone marrow, it does not cause leucopenia, anemia, or thrombocytopenia. This unique property makes it a preferred choice in regimens where bone marrow sparing is required. **Analysis of Incorrect Options:** * **Nephrotoxicity:** This is the most common and dose-limiting side effect. It occurs due to potent vasoconstriction of the afferent arterioles in the kidney. * **Hypertension:** Cyclosporine causes systemic vasoconstriction and sodium retention, leading to high blood pressure in approximately 50% of transplant patients. * **Hirsutism:** Excessive hair growth is a classic cosmetic side effect of Cyclosporine (unlike Tacrolimus, which is more associated with alopecia). **High-Yield NEET-PG Pearls:** * **The "6 H's" of Cyclosporine Toxicity:** **H**ypertension, **H**irsutism, **H**yperplasia (Gingival), **H**yperlipidemia, **H**yperkalemia, and **H**epatotoxicity. * **Gingival Hyperplasia:** Cyclosporine is a frequent cause of gum overgrowth (similar to Phenytoin and Nifedipine). * **Drug Interactions:** It is metabolized by **CYP3A4**; therefore, Grapefruit juice (inhibitor) increases its toxicity, while Rifampicin (inducer) decreases its efficacy. * **Monitoring:** Therapeutic Drug Monitoring (TDM) is essential due to its narrow therapeutic index.

Question 1

Therapeutic Drug Monitoring (TDM) is indicated for which of the following drugs, EXCEPT?

Accepted Answer

Metformin

Answer

Theophylline

Answer

Lithium

Answer

Phenytoin

Question 2

Which of the following statements about cetirizine is false?

Accepted Answer

It has good central nervous system penetration.

Answer

It is a second-generation antihistamine.

Answer

It is a metabolite of hydroxyzine.

Answer

It inhibits the release of histamine.

Question 3

Ramesh presented with bronchoconstriction, increased temperature, constipation, and tachycardia. What is the probable diagnosis?

Accepted Answer

Atropine poisoning

Answer

Mushroom poisoning

Answer

Arsenic poisoning

Answer

Organophosphorus poisoning

Question 4

Which of the following statements regarding carbon monoxide toxicity is FALSE?

Accepted Answer

Cytochrome toxicity is lethal

Answer

Treated by 5% CO2

Answer

PO2 is decreased

Answer

Shift HbO2 dissociation curve to left

Question 5

Pinpoint pupils are seen in all of the following conditions except?

Accepted Answer

Datura poisoning

Answer

Organophosphorus poisoning

Answer

Opioid poisoning

Answer

Cerebellopontine hemorrhage

Question 6

Which of the following drugs are used in the treatment of obesity?

Accepted Answer

All of the above

Answer

Orlistat

Answer

Sibutramine

Answer

Rimonabant

Question 7

Which of the following drugs has a narrow therapeutic index?

Accepted Answer

All of the above

Answer

Phenytoin

Answer

Lithium

Answer

Digoxin

Question 8

Which of the following medications aggravates myasthenia gravis?

Accepted Answer

Azathioprine

Answer

Aminoglycoside

Answer

Phenytoin

Answer

Tetracycline

Question 9

All of the following drugs can cause hepatic granuloma, EXCEPT:

Accepted Answer

Carbon tetrachloride

Answer

Quinidine

Answer

Sulfonamide

Answer

Carbamazepine

Question 10

Which of the following is NOT a side effect of cyclosporine?

Accepted Answer

Bone marrow suppression

Answer

Nephrotoxicity

Answer

Hypertension

Answer

Hirsutism

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?